Protective Effect of PCSK9 Inhibitor Against Negative Inflammatory Response and Organ Dysfunction After Coronary Artery Bypass Grafting (PANDA VIII)
Clinical trial NCT06730802 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06730802
- Sponsor
- Nanjing Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-01
- Primary completion
- 2026-12-31
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.